These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 22167613

  • 21. Treatment of IgA nephropathy with renal insufficiency.
    Pozzi C, Sarcina C, Ferrario F.
    J Nephrol; 2016 Aug; 29(4):551-8. PubMed ID: 26743078
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Progression of IgA nephropathy under current therapy regimen in a Chinese population.
    Li X, Liu Y, Lv J, Shi S, Liu L, Chen Y, Zhang H.
    Clin J Am Soc Nephrol; 2014 Mar; 9(3):484-9. PubMed ID: 24408121
    [Abstract] [Full Text] [Related]

  • 24. Modulating the progression in IgA nephropathy.
    Chan JC, Trachtman H.
    Nephron Clin Pract; 2006 Mar; 104(1):c61-8. PubMed ID: 16741372
    [Abstract] [Full Text] [Related]

  • 25. Cyclophosphamide pulse therapy in advanced progressive IgA nephropathy.
    Rasche FM, Klotz CH, Czock D, Karges W, Muche R, Jehle PM, Mertz A, Keller F.
    Nephron Clin Pract; 2003 Mar; 93(4):c131-6. PubMed ID: 12759581
    [Abstract] [Full Text] [Related]

  • 26. Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients.
    Vijan SG.
    J Indian Med Assoc; 2009 Mar; 107(3):178-82. PubMed ID: 19810392
    [Abstract] [Full Text] [Related]

  • 27. Supportive Versus Immunosuppressive Therapy of Progressive IgA nephropathy (STOP) IgAN trial: rationale and study protocol.
    Eitner F, Ackermann D, Hilgers RD, Floege J.
    J Nephrol; 2008 Mar; 21(3):284-9. PubMed ID: 18587715
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Long-term beneficial effects of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker therapy for patients with advanced immunoglobulin A nephropathy and impaired renal function.
    Moriyama T, Amamiya N, Ochi A, Tsuruta Y, Shimizu A, Kojima C, Itabashi M, Takei T, Uchida K, Nitta K.
    Clin Exp Nephrol; 2011 Oct; 15(5):700-707. PubMed ID: 21625892
    [Abstract] [Full Text] [Related]

  • 30. Treatment of progressive IgA nephropathy: an update.
    Wang W, Chen N.
    Contrib Nephrol; 2013 Oct; 181():75-83. PubMed ID: 23689569
    [Abstract] [Full Text] [Related]

  • 31. [Treatment of membranous glomerulonephritis: analysis of data from the Italian Renal Biopsy Registry].
    Garozzo M, Puliatti D, Battaglia GG.
    G Ital Nefrol; 2011 Oct; 28(4):425-30. PubMed ID: 21809312
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. A comparison of the effectiveness of cyclophosphamide, leflunomide, corticosteroids, or conservative management alone in patients with IgA nephropathy: a retrospective observational study.
    Chen S, Yin Q, Ren S, Zhong X, Wang W, Li G, Wang L.
    Sci Rep; 2018 Sep 12; 8(1):13662. PubMed ID: 30209279
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The effects of cytotoxic therapy in progressive IgA nephropathy.
    Shin JH, Lee JE, Park JH, Lim S, Jang HR, Kwon GY, Huh W, Jung SH, Kim YG, Oh HY, Kim DJ.
    Ann Med; 2016 Sep 12; 48(3):171-81. PubMed ID: 27031662
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Does angiotensin blockade influence graft outcome in renal transplant recipients with IgA nephropathy?
    Courtney AE, McNamee PT, Nelson WE, Maxwell AP.
    Nephrol Dial Transplant; 2006 Dec 12; 21(12):3550-4. PubMed ID: 16968729
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Combination therapy an ACE inhibitor and an angiotensin receptor blocker for IgA nephropathy: a meta-analysis.
    Cheng J, Zhang X, Tian J, Li Q, Chen J.
    Int J Clin Pract; 2012 Oct 12; 66(10):917-23. PubMed ID: 22994326
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.